US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder-February 2024-www.financetom.com

US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder

Nov 13, 2024 3:24 PM

Nov 13 (Reuters) - The U.S. Food and Drug Administration

approved PTC Therapeutics' ( PTCT ) gene therapy that is

administered directly in the brain to treat a potential fatal

enzyme deficiency disorder, the company said on Wednesday.

Previous page： Sterling Real Estate Trust Insider Bought Shares Worth $2,530,000, According to a Recent SEC Filing Next page： Northern Oil & Gas Closes $205 Million Acquisition of Delaware Basin Assets

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sterling Real Estate Trust Insider Bought Shares Worth $2,530,000, According to a Recent SEC Filing

Sep 28, 2024

04:35 PM EDT, 09/23/2024 (MT Newswires) -- Kenneth P Regan, 10% Owner, CEO, Trustee, on September 20, 2024, executed a purchase for 110,000 shares in Sterling Real Estate Trust (NONE) for $2,530,000. Following the Form 4 filing with the SEC, Regan has control over a total of 267,023 shares of the company, with 135,808 shares held directly and 131,215 controlled...

Northern Oil & Gas Closes $205 Million Acquisition of Delaware Basin Assets

Sep 28, 2024

05:21 PM EDT, 09/23/2024 (MT Newswires) -- Northern Oil & Gas (NOG) said Monday it has completed the acquisition of Delaware Basin assets from Point Energy Partners. The company said it paid $205 million for the assets that it acquired jointly with Vital Energy, which will operate the assets. Price: 37.19, Change: +0.05, Percent Change: +0.13 ...

Acadia Pharmaceuticals Appoints Catherine Adams as CEO

Sep 28, 2024

04:47 PM EDT, 09/23/2024 (MT Newswires) -- Acadia Pharmaceuticals ( ACAD ) said late Monday that it has appointed Catherine Adams as chief executive, succeeding Steve Davis. Adams most recently served as senior vice president and general manager of US at Bristol-Myers Squibb ( BMY ) , Acadia said. Shares of Acadia fell 2.7% in recent after-hours activity. Price: 15.85,...

Alexander & Baldwin Acquires Food Distribution Facility for $29.7 Million

Sep 28, 2024

04:34 PM EDT, 09/23/2024 (MT Newswires) -- Alexander & Baldwin Holdings (ALEX) said Monday that it completed the off-market acquisition of a 81,500 square foot food distribution facility in Pearl City, O'ahu, for $29.7 million. The facility is fully leased to C&S Wholesale Grocers' Hansen Distribution unit, according to Alexander & Baldwin. We expect this investment to be immediately accretive...